UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Volltextzugriff (PDF)

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Volltextzugriff (PDF)

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.189-195

2016

Volltextzugriff (PDF)

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Immunological reviews, 2011-01, Vol.239 (1), p.149-166

Graham, Barney S.

2011

Volltextzugriff (PDF)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Volltextzugriff (PDF)

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

The Journal of infectious diseases, 2020-02, Vol.221 (4), p.534-543

2020

Volltextzugriff (PDF)

Passive and active immunization against respiratory syncytial virus for the young and old

Expert review of vaccines, 2017-07, Vol.16 (7), p.737-749

2017

Volltextzugriff (PDF)

The CD4 T cell response to respiratory syncytial virus infection

Immunologic research, 2014-08, Vol.59 (1-3), p.109-117

2014

Volltextzugriff (PDF)

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Volltextzugriff (PDF)

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

PloS one, 2015-09, Vol.10 (9), p.e0138018-e0138018

2015

Volltextzugriff (PDF)

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

PloS one, 2013, Vol.8 (10), p.e77104

2013

Volltextzugriff (PDF)

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Vaccine, 2024-11, Vol.42 (25), p.126119, Article 126119

2024

Volltextzugriff (PDF)

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma

American journal of respiratory and critical care medicine, 2015-01, Vol.191 (1), p.34-44

2015

Volltextzugriff (PDF)

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Vaccine, 2020-01, Vol.38 (2), p.101-106

2020

Volltextzugriff (PDF)

Clinical and epidemiologic features of respiratory syncytial virus

Current topics in microbiology and immunology, 2013, Vol.372, p.39

2013

Volltextzugriff (PDF)

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

Neonatology (Basel, Switzerland), 2024, Vol.121 (3), p.271-282

2024

Volltextzugriff (PDF)

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

Expert review of anti-infective therapy, 2024-08, Vol.22 (8), p.631-645

2024

Volltextzugriff (PDF)

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

PLoS medicine, 2013-11, Vol.10 (11), p.e1001549-e1001549

2013

Volltextzugriff (PDF)

Respiratory syncytial virus vaccines: the future is bright

The lancet respiratory medicine, 2024-07, Vol.12 (7), p.499-499

The Lancet Respiratory Medicine

2024

Volltextzugriff (PDF)

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

The Lancet infectious diseases, 2015-12, Vol.15 (12), p.1398-1408

2015

Volltextzugriff (PDF)

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Current opinion in infectious diseases, 2015-06, Vol.28 (3), p.221-224

Munoz, Flor M

2015

Volltextzugriff (PDF)

Live-attenuated respiratory syncytial virus vaccines

Current topics in microbiology and immunology, 2013, Vol.372, p.259

2013

Volltextzugriff (PDF)

In vitro model for the assessment of human immune responses to subunit RSV vaccines

PloS one, 2020, Vol.15 (3), p.e0229660

2020

Volltextzugriff (PDF)

Antibody-mediated protection against respiratory syncytial virus in children

European respiratory review, 2024-10, Vol.33 (174), p.240106

2024

Volltextzugriff (PDF)

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Proceedings of the National Academy of Sciences - PNAS, 2011-06, Vol.108 (23), p.9619-9624

2011

Volltextzugriff (PDF)

1 – 25 von 2.166

Suche als RSS-Feed

Aktive Filter

ThemaInfant

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.010)
Mit Volltextzugriff
(1.437)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.150)
Science & Technology
(1.870)
Life Sciences & Biomedicine
(1.823)
Respiratory Syncytial Virus
(1.254)
Immunology
(1.168)
Child, Preschool
(1.107)
Female
(1.062)
Infectious Diseases
(1.017)
Male
(991)
Infant, Newborn
(882)
Biological And Medical Sciences
(750)
Child
(750)
Pediatrics
(678)
Medical Sciences
(652)
Respiratory Syncytial Virus Infections - Immunology
(566)
Respiratory Syncytial Viruses - Immunology
(561)
Microbiology
(555)
Viral Diseases
(423)
Respiratory Syncytial Virus Infections - Epidemiology
(416)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.152)
EZB Free E-Journals
(1.337)
Journals@Ovid Complete
(1.323)
Ingenta
(977)
Single Journals
(960)
IngentaConnect Journals
(559)
Elsevier ScienceDirect Journals Complete
(368)
Oxford University Press Journals Current
(350)
Oxford Journals 2020 Medicine
(327)
JSTOR
(326)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(299)
Wiley Online Library - AutoHoldings Journals
(264)
Wiley Online Library Full Collection 2018
(216)
Springer Nature - Complete Springer Journals
(75)
Taylor & Francis Journals
(63)
Taylor & Francis
(61)
Taylor & Francis Online
(56)
Nexis Uni
(45)
Nature
(45)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The race to make vaccines for a dangerous respiratory virus

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Passive and active immunization against respiratory syncytial virus for the young and old

The CD4 T cell response to respiratory syncytial virus infection

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Clinical and epidemiologic features of respiratory syncytial virus

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

Respiratory syncytial virus vaccines: the future is bright

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Live-attenuated respiratory syncytial virus vaccines

In vitro model for the assessment of human immune responses to subunit RSV vaccines

Antibody-mediated protection against respiratory syncytial virus in children

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Aktive Filter

Suchergebnisse filtern